APA

Soloway M. S., Briggman V., Carpinito G. A., Chodak G. W., Church P. A., Lamm D. L., Lange P., Messing E., Pasciak R. M., Reservitz G. B., Rukstalis D. B., Sarosdy M. F., Stadler W. M., Thiel R. P. & Hayden C. L. (19960820). Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. : The Journal of urology.

Chicago

Soloway M S, Briggman V, Carpinito G A, Chodak G W, Church P A, Lamm D L, Lange P, Messing E, Pasciak R M, Reservitz G B, Rukstalis D B, Sarosdy M F, Stadler W M, Thiel R P and Hayden C L. 19960820. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. : The Journal of urology.

Harvard

Soloway M. S., Briggman V., Carpinito G. A., Chodak G. W., Church P. A., Lamm D. L., Lange P., Messing E., Pasciak R. M., Reservitz G. B., Rukstalis D. B., Sarosdy M. F., Stadler W. M., Thiel R. P. and Hayden C. L. (19960820). Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. : The Journal of urology.

MLA

Soloway M S, Briggman V, Carpinito G A, Chodak G W, Church P A, Lamm D L, Lange P, Messing E, Pasciak R M, Reservitz G B, Rukstalis D B, Sarosdy M F, Stadler W M, Thiel R P and Hayden C L. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. : The Journal of urology. 19960820.